Vim-PSA Double-Target DBS for the Treatment of Holmes Tremor Secondary to Brainstem Hemorrhage: A Case Report
Overview
Overview
Journal
Int Med Case Rep J
Publisher
Dove Medical Press
Specialty
General Medicine
Date
2024 Jul 29
PMID
39071182
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We report the case of a 53-year-old man who was diagnosed with Holmes tremor and underwent deep brain stimulation of the ventro-intermediate thalamic nucleus and posterior subthalamic area. We assessed the patients' tremor with the Fahn-Tolosa-Marin Tremor Rating Scale at 1, 3, 6, 12 and 24 months after deep brain stimulation. Deep brain stimulation relieved the patient's tremor during the 24-month follow-up period.
References
1.
Patil S, Mishra V, Yadav N, Reddy P, Lochab B
. Dendrimer-Functionalized Nanodiamonds as Safe and Efficient Drug Carriers for Cancer Therapy: Nucleus Penetrating Nanoparticles. ACS Appl Bio Mater. 2022; 5(7):3438-3451.
DOI: 10.1021/acsabm.2c00373.
View
2.
Rombach I, Tillett W, Jadon D, Tucker L, Watson M, Francis A
. Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design. Trials. 2021; 22(1):185.
PMC: 7931500.
DOI: 10.1186/s13063-021-05142-7.
View
3.
Zhao H, Shi M, Yang F, Yang D, Hou X, Yang X
. Damage to the central nucleus of the thalamus via atypical Holmes tremor: a case report. J Int Med Res. 2021; 49(4):300060521999567.
PMC: 8024459.
DOI: 10.1177/0300060521999567.
View
4.
Shen J, Marsili L, Dwivedi A, Kuhlman G, Duker A, Espay A
. Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?. Cerebellum. 2022; 22(5):1039-1044.
DOI: 10.1007/s12311-022-01477-2.
View
5.
Liote F, Constantin A, Dahan E, Quiniou J, Frazier A, Sibilia J
. A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA). Rheumatology (Oxford). 2023; 63(2):516-524.
PMC: 10836978.
DOI: 10.1093/rheumatology/kead262.
View